A detailed history of National Bank Of Canada transactions in Avanos Medical, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 26 shares of AVNS stock, worth $502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 38 31.58%
Holding current value
$502
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$17.97 - $22.68 $215 - $272
-12 Reduced 31.58%
26 $0
Q4 2023

Feb 06, 2024

BUY
$17.64 - $22.99 $211 - $275
12 Added 46.15%
38 $0
Q1 2023

Apr 12, 2023

SELL
$26.92 - $31.75 $161 - $190
-6 Reduced 18.75%
26 $0
Q4 2022

Jan 24, 2023

BUY
$19.88 - $27.37 $39 - $54
2 Added 6.67%
32 $0
Q3 2022

Oct 13, 2022

SELL
$21.56 - $29.59 $6,899 - $9,468
-320 Reduced 91.43%
30 $1,000
Q2 2022

Jul 28, 2022

BUY
$24.87 - $34.68 $7,336 - $10,230
295 Added 536.36%
350 $10,000
Q4 2021

Jan 24, 2022

BUY
$29.25 - $36.02 $1,608 - $1,981
55 New
55 $2,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $898M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.